OBJECTIVES: To evaluate the association between self-reported condom use and prevalent and incident chlamydia, gonorrhea, and trichomoniasis. STUDY DESIGN: Prospective study of 414 males attending a sexually transmitted infection (STI) clinic in Jamaica. Condom use and STI status were assessed at enrollment and at 4 follow-up visits. RESULTS: The analyses on condom use and prevalent STI included data from 414 men, while those on incident STI were based on 1111 intervals from 355 men. We diagnosed prevalent STI (chlamydia, gonorrhea, and/or trichomoniasis) in 54.6% (n = 226) of the participants at enrollment. About 14% (n = 51) of participants had at least 1 of the study STIs during follow-up. Follow-up visits in which participants reported consistent condom use (100% of acts) for the past 7 days had less incident STI (adjusted OR, 0.4; 95% CI, 0.2-0.9) compared with visits where no condom use was reported. Self-reported condom use was more closely correlated with incident than prevalent STI. For example, the adjusted OR for prevalent infection for participants reporting consistent versus no condom use in past 7 days was 0.7 (95% CI, 0.4-1.2). Classifications based on the number of unprotected acts yielded findings similar to those based on the proportion of acts protected. CONCLUSIONS: Consistent condom use was associated with reduced risk of incident urethral STI. Research on condom effectiveness should focus on incident STI outcomes, where the temporal relationship between condom use and infection is clearer.
RCT Entities:
OBJECTIVES: To evaluate the association between self-reported condom use and prevalent and incident chlamydia, gonorrhea, and trichomoniasis. STUDY DESIGN: Prospective study of 414 males attending a sexually transmitted infection (STI) clinic in Jamaica. Condom use and STI status were assessed at enrollment and at 4 follow-up visits. RESULTS: The analyses on condom use and prevalent STI included data from 414 men, while those on incident STI were based on 1111 intervals from 355 men. We diagnosed prevalent STI (chlamydia, gonorrhea, and/or trichomoniasis) in 54.6% (n = 226) of the participants at enrollment. About 14% (n = 51) of participants had at least 1 of the study STIs during follow-up. Follow-up visits in which participants reported consistent condom use (100% of acts) for the past 7 days had less incident STI (adjusted OR, 0.4; 95% CI, 0.2-0.9) compared with visits where no condom use was reported. Self-reported condom use was more closely correlated with incident than prevalent STI. For example, the adjusted OR for prevalent infection for participants reporting consistent versus no condom use in past 7 days was 0.7 (95% CI, 0.4-1.2). Classifications based on the number of unprotected acts yielded findings similar to those based on the proportion of acts protected. CONCLUSIONS: Consistent condom use was associated with reduced risk of incident urethral STI. Research on condom effectiveness should focus on incident STI outcomes, where the temporal relationship between condom use and infection is clearer.
Authors: Margaret Christine Snead; Jeffrey Wiener; Sinmisola Ewumi; Christi Phillips; Lisa Flowers; Tina Hylton-Kong; Natalie Medley-Singh; Jennifer Legardy-Williams; Elizabeth Costenbader; John Papp; Lee Warner; Carolyn Black; Athena P Kourtis Journal: Sex Transm Infect Date: 2017-05-05 Impact factor: 3.519
Authors: Sharon A Abbott; Barbara A Friedland; Avina Sarna; Lauren L Katzen; Ulrike Rawiel; Aylur K Srikrishnan; C S Shalini; Waimar Tun; Christine A Kelly; Suniti Solomon; Barbara S Mensch Journal: AIDS Behav Date: 2013-07
Authors: Danielle Chiaramonte; Robin Lin Miller; KyungSook Lee; Olga J Santiago Rivera; Ignacio D Acevedo-Polakovich; Sara McGirr; Jennifer L Porter; Jonathan M Ellen; Cherrie B Boyer Journal: AIDS Care Date: 2020-02-02
Authors: Muazzam Nasrullah; Emeka Oraka; Pollyanna R Chavez; Christopher H Johnson; Elizabeth DiNenno Journal: J Sex Med Date: 2017-04 Impact factor: 3.802
Authors: Elena Regushevskaya; Tatiana Dubikaytis; Made Laanpere; Minna Nikula; Olga Kuznetsova; Hele Karro; Elina Haavio-Mannila; Elina Hemminki Journal: Int J Public Health Date: 2010-06-30 Impact factor: 3.380
Authors: Paul C Hewett; Barbara S Mensch; Manoel Carlos S de A Ribeiro; Heidi E Jones; Sheri A Lippman; Mark R Montgomery; Janneke H H M van de Wijgert Journal: Am J Epidemiol Date: 2008-06-04 Impact factor: 4.897